http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104958304-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104958304-B |
| titleOfInvention | A kind of application of carbon-21 steride compound STA in preparing Hedgehog pathway inhibitors and anticancer drug |
| abstract | The present invention provides a kind of applications of carbon-21 steride compound STA in preparing Hedgehog pathway inhibitors and anticancer drug, the structural formula of the carbon-21 steride compound STA is： The cancer includes but not limited to basal-cell carcinoma, medulloblastoma, rhabdomyosarcoma, cancer of pancreas, breast cancer, meningioma, glioblastoma, melanoma, gastric cancer, liver cancer, cancer of the esophagus, cholangiocarcinoma, prostate cancer, colon cancer, Small Cell Lung Cancer, non-small cell lung cancer, Deiter's cells cancer, Huppert's disease, urogenital neoplasm and leukaemia.It is confirmed through experimental result, which, which has, inhibits Hedgehog accesses and inducing apoptosis of tumour cell double effects. |
| priorityDate | 2015-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.